These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
167 related articles for article (PubMed ID: 7904286)
21. Role of endogenously released cholecystokinin in determining postprandial insulin levels in man: effects of loxiglumide, a specific cholecystokinin receptor antagonist. Baum F; Nauck MA; Ebert R; Cantor P; Hoffmann G; Choudhury AR; Schmidt WE; Creutzfeldt W Digestion; 1992; 53(3-4):189-99. PubMed ID: 1291406 [TBL] [Abstract][Full Text] [Related]
22. Physiological role of cholecystokinin on postprandial insulin secretion and gastric meal emptying in man. Studies with the cholecystokinin receptor antagonist loxiglumide. Fried M; Schwizer W; Beglinger C; Keller U; Jansen JB; Lamers CB Diabetologia; 1991 Oct; 34(10):721-6. PubMed ID: 1959704 [TBL] [Abstract][Full Text] [Related]
23. Cholecystokinin's role in regulation of colonic motility in health and in irritable bowel syndrome. Niederau C; Faber S; Karaus M Gastroenterology; 1992 Jun; 102(6):1889-98. PubMed ID: 1587408 [TBL] [Abstract][Full Text] [Related]
24. Role of cholecystokinin in the regulation of gastric emptying and pancreatic enzyme secretion in humans. Studies with the cholecystokinin-receptor antagonist loxiglumide. Fried M; Erlacher U; Schwizer W; Löchner C; Koerfer J; Beglinger C; Jansen JB; Lamers CB; Harder F; Bischof-Delaloye A Gastroenterology; 1991 Aug; 101(2):503-11. PubMed ID: 2065926 [TBL] [Abstract][Full Text] [Related]
25. Effect of a cholecystokinin antagonist on meal-stimulated insulin and pancreatic polypeptide release in humans. Hildebrand P; Ensinck JW; Ketterer S; Delco F; Mossi S; Bangerter U; Beglinger C J Clin Endocrinol Metab; 1991 May; 72(5):1123-9. PubMed ID: 2022712 [TBL] [Abstract][Full Text] [Related]
27. CCK receptor antagonism by loxiglumide and gall bladder contractions in response to cholecystokinin, sham feeding and ordinary feeding in man. Konturek JW; Konturek SJ; Kurek A; Bogdal J; Oleksy J; Rovati L Gut; 1989 Aug; 30(8):1136-42. PubMed ID: 2767511 [TBL] [Abstract][Full Text] [Related]
28. Eradication of Helicobacter pylori and gastrin-somatostatin link in duodenal ulcer patients. Konturek JW; Bielański W; Konturek SJ; Domschke W J Physiol Pharmacol; 1996 Mar; 47(1):161-75. PubMed ID: 8777296 [TBL] [Abstract][Full Text] [Related]
29. Effects of cholecystokinin receptor blockade on circulating concentrations of glucose, insulin, C-peptide, and pancreatic polypeptide after various meals in healthy human volunteers. Niederau C; Schwarzendrube J; Lüthen R; Niederau M; Strohmeyer G; Rovati L Pancreas; 1992; 7(1):1-10. PubMed ID: 1557335 [TBL] [Abstract][Full Text] [Related]
30. Effect of loxiglumide on gallbladder contractile response to cerulein and food in humans. Malesci A; De Fazio C; Festorazzi S; Bonato C; Valentini A; Tacconi M; Rovati L; Setnikar I Gastroenterology; 1990 May; 98(5 Pt 1):1307-10. PubMed ID: 2323521 [TBL] [Abstract][Full Text] [Related]
31. Effects of CCK receptor blockade on intestinal motor activity in conscious dogs. Niederau C; Karaus M Am J Physiol; 1991 Feb; 260(2 Pt 1):G315-24. PubMed ID: 1996649 [TBL] [Abstract][Full Text] [Related]
32. Interaction of the cholinergic system and cholecystokinin in the regulation of endogenous and exogenous stimulation of pancreatic secretion in humans. Adler G; Beglinger C; Braun U; Reinshagen M; Koop I; Schafmayer A; Rovati L; Arnold R Gastroenterology; 1991 Feb; 100(2):537-43. PubMed ID: 1702077 [TBL] [Abstract][Full Text] [Related]
33. Role of gastrin/CCK-B receptors in meal-stimulated acid secretion in rats. Aurang K; Spraggs CF; Jordan C; Lloyd KC Am J Physiol; 1997 May; 272(5 Pt 1):G1243-8. PubMed ID: 9176236 [TBL] [Abstract][Full Text] [Related]
34. Cholecystokinin receptor antagonist loxiglumide: influence on bilio-pancreatic secretion and gastrointestinal hormones in man. Schmidt WE; Creutzfeldt W; Höcker M; Choudhury AR; Nustede R; Schleser A; Nitsche R; Rovati LC; Schafmayer A; Fölsch UR Digestion; 1990; 46 Suppl 2():232-9. PubMed ID: 2262057 [TBL] [Abstract][Full Text] [Related]
35. Role of cholecystokinin in the control of gastric acid secretion and gastrin release in dogs and healthy and duodenal ulcer subjects. Konturek JW; Konturek SJ; Domschke W Scand J Gastroenterol; 1993 Aug; 28(8):657-60. PubMed ID: 8105530 [No Abstract] [Full Text] [Related]
36. Effect of a low dose of intraduodenal fat on satiety in humans: studies using the type A cholecystokinin receptor antagonist loxiglumide. Lieverse RJ; Jansen JB; Masclee AA; Rovati LC; Lamers CB Gut; 1994 Apr; 35(4):501-5. PubMed ID: 8174988 [TBL] [Abstract][Full Text] [Related]
37. Cholecystokinin (CCK) in the amino acid uptake and enzyme protein secretion by the pancreas in humans. Konturek JW; Gabryelewicz A; Kulesza E; Konturek SJ; Domschke W Int J Pancreatol; 1995 Feb; 17(1):55-61. PubMed ID: 8568335 [TBL] [Abstract][Full Text] [Related]
39. Effects of lorglumide on gastrin- and peptone-stimulated gastric acid secretion in rats. van de Brug FJ; Jansen JB; Kuijpers IJ; Lamers CB Life Sci; 1990; 47(26):2459-64. PubMed ID: 2263169 [TBL] [Abstract][Full Text] [Related]
40. Role of gastrin and cholecystokinin receptors in regulation of peptone-stimulated gastric acid secretion in conscious rats. Varga G; Campbell DR; Bussjaeger LJ; Solomon TE Eur J Pharmacol; 1993 Nov; 250(1):37-42. PubMed ID: 8119323 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]